2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Recruiting
1
Sponsor Class
INDUSTRY
2
OTHER_GOV
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Colorectal Neoplasms
28
Neoplasms
13
Colonic Neoplasms
12
Breast Neoplasms
12
Prostatic Neoplasms
9
Polycythemia Vera
9
Venous Thromboembolism
8
Multiple Myeloma
8
Recurrence
6
Carcinoma, Non-Small-Cell Lung
6
Rectal Neoplasms
5
Thrombocythemia, Essential
4
Ovarian Neoplasms
4
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Esophageal Neoplasms
4
Cardiovascular Diseases
4
Barrett Esophagus
4
Stomach Neoplasms
3
Precancerous Conditions
3
Melanoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Adenomatous Polyps
3
Adenoma
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Smoking Cessation
2
Interventions
Oxaliplatin
295
Capecitabine
209
Fluorouracil
183
Cisplatin
172
Docetaxel
140
S 1 (combination)
135
Paclitaxel
128
Leucovorin
117
Irinotecan
110
pembrolizumab
104
Trastuzumab
76
Nivolumab
59
apatinib
57
Drug Therapy
52
sintilimab
46
Surgical Procedures, Operative
45
Ramucirumab
40
Radiotherapy
40
Bevacizumab
37
Hyperthermic Intraperitoneal Chemotherapy
34
Epirubicin
32
titanium silicide
31
tislelizumab
31
Carboplatin
31
Gastrectomy
28
Cyclophosphamide
27
XELOX
25
Tegafur
24
Folfox protocol
23
Albumin-Bound Paclitaxel
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Aspirin
×
Clear all
NCT04214990
2024-12-27
EASTERN
National Cancer Center, Korea
Phase 3
Recruiting
1,700 enrolled
NCT04081831
2022-04-19
ENgAGE-HK
Bayer
Completed
99,999 enrolled
NCT03743883
2020-06-01
ENgAGE-UK
Bayer
Completed
99,999 enrolled